Grant: Discovery Grants Program - Individual
McGill University
$25,000.00
Mechanism of human valve interstitial cell calcification
EF 2017-18
Résumé
Overall aims: The general aim of the current proposal is to determine mechanism of the human aortic valve interstitial cell (HAVIC) mineralization in relation to increases in lipoprotein(a)[Lp(a)] and oxidized phospholipids (OxPLs). Background and Rationale: Although historically HAVIC mineralization (calcification) thought to be a degenerative process, recent studies have pointed to other possible causes such as shear-stress, angiotensin system and hyperlipidemia. Lp(a) is composed of the glycoprotein apolipoprotein (a) [apo(a)] attached to apolipoprotein B-100, found in a particle highly similar to low density lipoprotein (LDL). Lp(a) also binds to OxPLs in plasma and up taken in tissue by scavenger receptors. Studies utilizing transgenic mice have supported a relationship between Lp(a) serum levels and mineralization of blood vessels. Although these studies point to a possible relationship between Lp(a) and vascular stiffness, only recent genetic population studies have pointed to an a potentially important role for Lp(a) in aortic valve calcification. How Lp(a) induces HAVICs mineralization, and the mechanisms involved remains to be determined. General Hypothesis: Lp(a) is uptaken by HAVICs by endocytosis or receptor binding, and subsequently decreasing cholesterol efflux and inducing mineralization and apoptosis through increased matrix vesicles (MVs) formation and reactive oxygen species (ROS). Interfering with Lp(a) and/or downstream signalling pathway would ameliorate HAVICs mineralization. Experimental design: We plan to determine the mechanism of: 1) Lp(a) uptake and/or binding in HAVICs? HAVICs express ABCA1, LDL-R, SRB-1 and LRP5/6. Here, we shall assess Lp(a) catabolism and cholesterol efflux in HAVICs. 2) Lp(a) induced HAVICs mineralization? When HAVICs undergo mineralization they produce a large number of calcium-phosphate containing matrix vesicles (MVs). Our preliminary data showed that treatment of HAVICs with Lp(a) significantly increased the number of MVs and expression of proteins and genes involved in the biogenesis of MVs accompanied by a significant reduction in Fetuin-A. Here, we plan to isolate and characterize these MVs using ultracentrifugation, NanoSight, flow cytometry and electron microscopy. We also plan to identify the functional profiles of these MVs using quantitative proteomics in order to interfere with the pathways of downstream mediators of Lp(a)-induced effects in HAVICs. 3) Lp(a)-induced HAVICs apoptosis. Here, we plan to determine the levels of ROS and monitor mitochondrial transmembrane potential in response to Lp(a). 4) In vivo effects of Lp(a) overexpression/inhibition and the mechanism involved. In the short term, the proposed work will determine the mechanism of HAVICs mineralization, and in the long term serves as an excellent platform for the training of graduate students and post-doctoral fellows.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
RGPIN-2017-05328
Name nom
Schwertani, Adel
Department département
Medicine - Medicine
Organization id
61
Institution établissement
McGill University
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2017
Competition year année de concours
2017
Award amount
25000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1502
Committee name en
Biological Systems and Functions
Committee name fr
Systèmes et fonctions biologiques
Area of application code
1211
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Medical and health sciences
Area of application fr
Sciences médicales et de la santé
Research subject code
5111
Research subject group en
Cell biology
Research subject group fr
Biologie cellulaire
Research subject en
Signal transduction
Research subject fr
Transduction de signal
Partie
1
Nb partie
5
Application title
Mechanism of human valve interstitial cell calcification
Keyword
NSERC
Application summary
Overall aims: The general aim of the current proposal is to determine mechanism of the human aortic valve interstitial cell (HAVIC) mineralization in relation to increases in lipoprotein(a)[Lp(a)] and oxidized phospholipids (OxPLs). Background and Rationale: Although historically HAVIC mineralization (calcification) thought to be a degenerative process, recent studies have pointed to other possible causes such as shear-stress, angiotensin system and hyperlipidemia. Lp(a) is composed of the glycoprotein apolipoprotein (a) [apo(a)] attached to apolipoprotein B-100, found in a particle highly similar to low density lipoprotein (LDL). Lp(a) also binds to OxPLs in plasma and up taken in tissue by scavenger receptors. Studies utilizing transgenic mice have supported a relationship between Lp(a) serum levels and mineralization of blood vessels. Although these studies point to a possible relationship between Lp(a) and vascular stiffness, only recent genetic population studies have pointed to an a potentially important role for Lp(a) in aortic valve calcification. How Lp(a) induces HAVICs mineralization, and the mechanisms involved remains to be determined. General Hypothesis: Lp(a) is uptaken by HAVICs by endocytosis or receptor binding, and subsequently decreasing cholesterol efflux and inducing mineralization and apoptosis through increased matrix vesicles (MVs) formation and reactive oxygen species (ROS). Interfering with Lp(a) and/or downstream signalling pathway would ameliorate HAVICs mineralization. Experimental design: We plan to determine the mechanism of: 1) Lp(a) uptake and/or binding in HAVICs? HAVICs express ABCA1, LDL-R, SRB-1 and LRP5/6. Here, we shall assess Lp(a) catabolism and cholesterol efflux in HAVICs. 2) Lp(a) induced HAVICs mineralization? When HAVICs undergo mineralization they produce a large number of calcium-phosphate containing matrix vesicles (MVs). Our preliminary data showed that treatment of HAVICs with Lp(a) significantly increased the number of MVs and expression of proteins and genes involved in the biogenesis of MVs accompanied by a significant reduction in Fetuin-A. Here, we plan to isolate and characterize these MVs using ultracentrifugation, NanoSight, flow cytometry and electron microscopy. We also plan to identify the functional profiles of these MVs using quantitative proteomics in order to interfere with the pathways of downstream mediators of Lp(a)-induced effects in HAVICs. 3) Lp(a)-induced HAVICs apoptosis. Here, we plan to determine the levels of ROS and monitor mitochondrial transmembrane potential in response to Lp(a). 4) In vivo effects of Lp(a) overexpression/inhibition and the mechanism involved. In the short term, the proposed work will determine the mechanism of HAVICs mineralization, and in the long term serves as an excellent platform for the training of graduate students and post-doctoral fellows.